Risk of higher dose methotrexate for renal impairment in patients with rheumatoid arthritis

Renal impairment is a major concern in patients taking high-dose methotrexate (MTX) for malignancy, but it has not been fully explored in rheumatoid arthritis (RA) patients taking low-dose MTX. This study aimed to elucidate the dose-dependent effects of MTX on the renal function of patients with RA....

Descripción completa

Detalles Bibliográficos
Autores principales: Hayashi, Keigo, Sada, Ken-Ei, Asano, Yosuke, Asano, Sumie Hiramatsu, Yamamura, Yuriko, Ohashi, Keiji, Morishita, Michiko, Watanabe, Haruki, Narazaki, Mariko, Matsumoto, Yoshinori, Wada, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599222/
https://www.ncbi.nlm.nih.gov/pubmed/33127957
http://dx.doi.org/10.1038/s41598-020-75655-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599222/
https://www.ncbi.nlm.nih.gov/pubmed/33127957
http://dx.doi.org/10.1038/s41598-020-75655-9

Ejemplares similares